 CAMBRIDGE, Mass., Aug. 02, 2022 GLOBE NEWSWIRE -- Voyager Therapeutics, Inc. Nasdaq: VYGR, a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus AAV capsids, will report second quarter 2022 financial and operating results after market close on Thursday, August 4, 2022. Subsequently, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss its financial and operating results and provide a corporate update. 